Forbion

Forbion Forbion is a major European life sciences VC managing €5B in AUM following a massive 2024 raise. That year alone, the firm raised over €2B. Growth Opportunities III at €1.2B and Ventures VII at €890M. Additionally, a €200M BioEconomy Fund I targets biotech sustainability. Over two decades, the firm has made 128 investments with 58 currently active. The team led or co-led 88% of initial investment rounds. Recent exits include Yellow Jersey Therapeutics, Mariana Oncology, and Aiolos Bio.